This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

ILC Dover Expands Life Sciences Presence with Water for Injection (WFI) and Custom Chemical Solutions

Newswire.ca - Tue May 26, 9:08AM CDT

WFI manufacturing and other capabilities support for pharmaceutical innovation, GLP‑1 therapies, and medical devices.

LILLINGTON, N.C., May 26, 2026 /CNW/ -- ILC Dover, an Ingersoll Rand business and world leader in the innovative design and production for biopharmaceutical, pharmaceutical, and medical device markets, recently invested in two new core capabilities--Water for Injection (WFI) quality water and custom chemical solutions. This is a significant expansion that further strengthens the company's growing presence in the life sciences market.

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).